Learned helplessness

From WikiMD's WELLNESSPEDIA

A dog in a shuttle box experiment, illustrating learned helplessness.

Learned helplessness is a psychological condition in which an individual learns to believe that they have no control over the outcome of a situation, even when they do have the power to change their circumstances. This phenomenon was first identified by psychologists Martin Seligman and Steven Maier in the 1960s through experiments with dogs.

History[edit]

The concept of learned helplessness emerged from research conducted by Seligman and Maier. In their experiments, dogs were subjected to a series of electric shocks from which they could not escape. Over time, these dogs stopped trying to avoid the shocks, even when they were later placed in a situation where escape was possible. This behavior was termed "learned helplessness."

Mechanism[edit]

Learned helplessness occurs when an individual is repeatedly exposed to an aversive stimulus that they cannot escape or avoid. Over time, the individual learns to become passive and accept the situation, even when opportunities to change it are available. This is thought to be due to a cognitive shift where the individual believes that their actions have no effect on the outcome.

Implications[edit]

Learned helplessness has significant implications for understanding depression, anxiety, and other mental health disorders. It suggests that individuals who experience uncontrollable stressors may develop a sense of helplessness that contributes to the onset of these conditions. This concept has been applied to various fields, including education, where it helps explain why some students may give up on learning tasks.

Applications[edit]

In clinical psychology, learned helplessness is used to understand and treat conditions like depression. Therapeutic approaches may focus on helping individuals regain a sense of control and efficacy. In education, strategies are developed to prevent learned helplessness by fostering a growth mindset and resilience in students.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.